Michael Brezinsky, MD
Internal Medicine · Montrose, CONPI 1245233378
Payments from drug & device makers
Across 5 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$30
- Meridian Bioscience Inc.$23
- Exact Sciences$21
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$14
- Fisher Scientific Company L.L.C.$13
What the payments were for
- Food & beverage$101100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $30 |
| Meridian Bioscience Inc. | 1 | $23 |
| Exact Sciences | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Fisher Scientific Company L.L.C. | 1 | $13 |
How this compares
$101 in reported general payments places this provider in the 55th percentile of 1,430 internal medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 127 | $119,031 |
| OzempicSemaglutide | 66 | $62,927 |
| JardianceEmpagliflozin | 38 | $44,649 |
| XareltoRivaroxaban | 29 | $40,580 |
| CreonLipase/Protease/Amylase | 12 | $35,433 |
| WegovySemaglutide | 17 | $29,851 |
| TrulicityDulaglutide | 19 | $19,775 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $18,191 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $11,246 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $9,931 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $4,080 |
| Atorvastatin Calcium | 490 | $4,061 |
| Levothyroxine Sodium | 373 | $3,266 |
| Pantoprazole Sodium | 203 | $3,126 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 73 | $2,560 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Montrose
- Stanton ElziWheat Ridge$9.2M
- Jason HenryDenver$7.3M
- Kenneth CohenLakewood$4.5M
- Luke WebbColorado Springs$2.1M
- Alexis LealAurora$2M
- Mauricio WaintrubAurora$1.3M
- Steven BrodieColorado Springs$883K
- Monica GrafalsAvon$673K
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.